The global Botanical Drug market size was valued at USD 33630 million in 2022 and is forecast to a readjusted size of USD 43740 million by 2029 with a CAGR of 3.8% during review period.
Sales outsourcing is simply this: outsourcing a portion or entire sales activities to a trusted 3rd party sales team. Using a sales outsourcing partner allows companies to attract and maintain a sales force without having to make them full or part-time employees.
Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, etc. are the leaders of the industry. Asia-Pacific is the largest consumption place, with a consumption market share nearly 75% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 16%. The classification of Botanical Drug includes Prescription Drug and OTC, and the proportion of OTC in 2019 was about 61%. Botanical Drug is widely used for Cardiovascular, Tumor, Respiratory System, Others. The most proportion of Botanical Drug is Cardiovascular, and the proportion in 2019 was 30%.
This report is a detailed and comprehensive analysis for global Botanical Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Botanical Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Botanical Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Botanical Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Botanical Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Botanical Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Botanical Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
Prescription Drug
OTC
Cardiovascular
Tumor
Respiratory System
Others
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Strengths:
- Increasing consumer preference for natural and plant-based remedies boosts demand for botanical drugs.
- Growing awareness of the therapeutic benefits of botanical drugs in chronic disease management and overall wellness.
Weaknesses:
- Regulatory hurdles and stringent approvals for botanical drug development can delay market entry.
- Variability in plant quality and potency can lead to inconsistent drug efficacy.
Opportunities:
- Expansion of the global herbal medicine market, especially in emerging economies, provides growth potential.
- Rising research and development activities in botanical-based drug formulations for new therapeutic areas.
Threats:
- Competition from synthetic drugs and pharmaceutical companies may limit market share for botanical drugs.
- Environmental factors such as climate change could affect the availability and consistency of key botanical resources.
Political:
- Increasing government support for herbal medicine and traditional practices can enhance market growth.
- Regulatory frameworks and policies concerning herbal drug approvals may vary significantly across regions, impacting market access.
Economic:
- Rising disposable incomes and health awareness among consumers can drive demand for botanical drugs.
- Economic fluctuations may influence consumer spending on alternative medicines, potentially affecting market stability.
Social:
- Growing trends toward holistic health and wellness promote the use of botanical drugs among consumers.
- Increased focus on sustainability and environmental conservation can lead to greater interest in plant-based therapies.
Technological:
- Advances in biotechnology and extraction methods improve the efficiency and efficacy of botanical drug development.
- Innovations in research tools and clinical studies enhance the understanding of the therapeutic properties of botanical substances.
Environmental:
- Sustainable sourcing practices for botanical ingredients are becoming essential due to environmental concerns.
- Climate change poses a risk to the availability of certain plant species used in botanical drugs, affecting supply chains.
Legal:
- Intellectual property rights and patent issues can impact the development and commercialization of botanical drugs.
- Compliance with international quality standards and regulations is crucial for market entry and product acceptance.
Suppliers:
- Farmers and suppliers of raw botanical materials provide the necessary plant sources for drug formulation.
- Research institutions and pharmaceutical companies contribute to the development and testing of botanical drugs.
Inputs:
- Quality botanical extracts and ingredients serve as the primary inputs for drug formulation and development.
- Regulatory documentation and clinical trial data are essential for market approval and compliance.
Process:
- Extraction and purification processes are used to obtain active compounds from botanical sources.
- Clinical trials and regulatory submissions ensure the safety and efficacy of botanical drugs before market release.
Outputs:
- Finalized botanical drug products are launched for consumer use, offering therapeutic benefits.
- Research findings and clinical data are published to inform healthcare professionals and consumers about the efficacy of botanical drugs.
Customers:
- Healthcare providers and practitioners utilize botanical drugs in treatment regimens for patients seeking alternative therapies.
- Consumers, including health-conscious individuals and those seeking natural remedies, represent a growing market segment for botanical products.
Threat of New Entrants:
- Low barriers to entry in terms of plant sourcing and formulation processes, encouraging new players to enter the market.
- However, strict regulatory requirements and the need for extensive clinical trials can discourage some new entrants.
Bargaining Power of Suppliers:
- The availability of quality raw materials from specialized suppliers gives them significant bargaining power in the market.
- Limited availability of certain botanical ingredients can increase supplier power and affect pricing.
Bargaining Power of Buyers:
- Consumers have increasing options for both synthetic and natural drug alternatives, giving them strong bargaining power.
- However, brand loyalty and trust in quality botanical products can reduce the bargaining power of individual buyers.
Threat of Substitutes:
- The presence of synthetic drugs and other alternative therapies such as dietary supplements poses a strong threat of substitution.
- Traditional pharmaceutical options may offer more consistent efficacy, challenging the adoption of botanical drugs.
Industry Rivalry:
- Competition among established pharmaceutical companies and new herbal medicine startups intensifies the rivalry in the botanical drug market.
- Differentiation in product offerings, quality, and brand reputation plays a key role in reducing competitive pressure.
Raw Material Sourcing:
- Dependence on sustainable and reliable cultivation of medicinal plants is crucial to maintain a consistent supply chain.
- Variability in plant yields due to environmental factors or climate change can disrupt raw material availability.
Suppliers and Vendors:
- Partnerships with specialized botanical ingredient suppliers ensure access to high-quality and standardized raw materials.
- Limited number of certified suppliers for rare or exotic plants increases competition and potential costs.
Research and Development:
- Advanced extraction technologies and analytical methods are vital in isolating active compounds from plant sources.
- Collaborations with academic institutions and research organizations enhance the development of innovative botanical formulations.
Regulatory Compliance:
- Compliance with stringent regulations for raw material sourcing and production ensures market acceptance.
- Certification and quality control processes, such as Good Agricultural and Collection Practices (GACP), are essential for meeting regulatory standards.
Manufacturing Processes:
- Standardized manufacturing techniques, such as advanced extraction and formulation technologies, ensure consistent product quality.
- Good Manufacturing Practices (GMP) compliance is essential to maintain product integrity and regulatory approval.
Logistics and Supply Chain Management:
- Efficient distribution networks are required to meet the growing global demand for botanical drugs in a timely manner.
- Challenges such as temperature-sensitive storage and transportation conditions must be addressed to preserve product efficacy.
Quality Control and Testing:
- Rigorous quality assurance measures, including analytical testing and bioassays, ensure the safety and efficacy of botanical products.
- Third-party certifications and audits enhance consumer confidence and regulatory compliance.
Market Readiness:
- Strategic partnerships with distributors and pharmacies facilitate smoother market entry and product availability.
- Effective marketing and branding strategies are necessary to distinguish botanical drugs in a competitive healthcare market.
Distribution Channels:
- Botanical drugs are distributed through retail pharmacies, online platforms, and direct-to-consumer channels, expanding accessibility.
- Partnerships with healthcare providers and institutions help integrate botanical drugs into formal treatment regimens.
End-User Segments:
- Patients seeking alternative and complementary therapies form a significant portion of the consumer base.
- Healthcare professionals, including integrative medicine practitioners, play a key role in recommending botanical drugs.
Consumer Behavior:
- Increasing health consciousness and preference for natural remedies drive consumer interest in botanical drugs.
- Trust in product quality, efficacy, and safety influences purchasing decisions and brand loyalty.
Post-Market Surveillance:
- Continuous monitoring of consumer feedback and adverse events is critical for improving products and maintaining regulatory compliance.
- Engaging with end-users through education and awareness campaigns enhances long-term market sustainability.
Chapter 1, to describe Botanical Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Botanical Drug, with revenue, gross margin and global market share of Botanical Drug from 2018 to 2023.
Chapter 3, the Botanical Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Botanical Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Botanical Drug.
Chapter 13, to describe Botanical Drug research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Botanical Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Botanical Drug by Type
1.3.1 Overview: Global Botanical Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Botanical Drug Consumption Value Market Share by Type in 2022
1.3.3 Prescription Drug
1.3.4 OTC
1.4 Global Botanical Drug Market by Application
1.4.1 Overview: Global Botanical Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cardiovascular
1.4.3 Tumor
1.4.4 Respiratory System
1.4.5 Others
1.5 Global Botanical Drug Market Size & Forecast
1.6 Global Botanical Drug Market Size and Forecast by Region
1.6.1 Global Botanical Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Botanical Drug Market Size by Region, (2018-2029)
1.6.3 North America Botanical Drug Market Size and Prospect (2018-2029)
1.6.4 Europe Botanical Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Botanical Drug Market Size and Prospect (2018-2029)
1.6.6 South America Botanical Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Botanical Drug Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Buchang Pharmaceuticals
2.1.1 Buchang Pharmaceuticals Details
2.1.2 Buchang Pharmaceuticals Major Business
2.1.3 Buchang Pharmaceuticals Botanical Drug Product and Solutions
2.1.4 Buchang Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Buchang Pharmaceuticals Recent Developments and Future Plans
2.2 China TCM
2.2.1 China TCM Details
2.2.2 China TCM Major Business
2.2.3 China TCM Botanical Drug Product and Solutions
2.2.4 China TCM Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 China TCM Recent Developments and Future Plans
2.3 Tsumura
2.3.1 Tsumura Details
2.3.2 Tsumura Major Business
2.3.3 Tsumura Botanical Drug Product and Solutions
2.3.4 Tsumura Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Tsumura Recent Developments and Future Plans
2.4 Schwabe
2.4.1 Schwabe Details
2.4.2 Schwabe Major Business
2.4.3 Schwabe Botanical Drug Product and Solutions
2.4.4 Schwabe Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Schwabe Recent Developments and Future Plans
2.5 Tong Ren Tang
2.5.1 Tong Ren Tang Details
2.5.2 Tong Ren Tang Major Business
2.5.3 Tong Ren Tang Botanical Drug Product and Solutions
2.5.4 Tong Ren Tang Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Tong Ren Tang Recent Developments and Future Plans
2.6 Jumpcan Pharmaceutical
2.6.1 Jumpcan Pharmaceutical Details
2.6.2 Jumpcan Pharmaceutical Major Business
2.6.3 Jumpcan Pharmaceutical Botanical Drug Product and Solutions
2.6.4 Jumpcan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Jumpcan Pharmaceutical Recent Developments and Future Plans
2.7 Guangzhou Baiyunshan Pharmaceutical
2.7.1 Guangzhou Baiyunshan Pharmaceutical Details
2.7.2 Guangzhou Baiyunshan Pharmaceutical Major Business
2.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product and Solutions
2.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments and Future Plans
2.8 Yunnan Baiyao
2.8.1 Yunnan Baiyao Details
2.8.2 Yunnan Baiyao Major Business
2.8.3 Yunnan Baiyao Botanical Drug Product and Solutions
2.8.4 Yunnan Baiyao Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Yunnan Baiyao Recent Developments and Future Plans
2.9 Tasly Holding Group
2.9.1 Tasly Holding Group Details
2.9.2 Tasly Holding Group Major Business
2.9.3 Tasly Holding Group Botanical Drug Product and Solutions
2.9.4 Tasly Holding Group Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Tasly Holding Group Recent Developments and Future Plans
2.10 Bionorica Se
2.10.1 Bionorica Se Details
2.10.2 Bionorica Se Major Business
2.10.3 Bionorica Se Botanical Drug Product and Solutions
2.10.4 Bionorica Se Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Bionorica Se Recent Developments and Future Plans
2.11 Huarun 999
2.11.1 Huarun 999 Details
2.11.2 Huarun 999 Major Business
2.11.3 Huarun 999 Botanical Drug Product and Solutions
2.11.4 Huarun 999 Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Huarun 999 Recent Developments and Future Plans
2.12 Taiji
2.12.1 Taiji Details
2.12.2 Taiji Major Business
2.12.3 Taiji Botanical Drug Product and Solutions
2.12.4 Taiji Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Taiji Recent Developments and Future Plans
2.13 Weleda
2.13.1 Weleda Details
2.13.2 Weleda Major Business
2.13.3 Weleda Botanical Drug Product and Solutions
2.13.4 Weleda Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Weleda Recent Developments and Future Plans
2.14 Kwangdong
2.14.1 Kwangdong Details
2.14.2 Kwangdong Major Business
2.14.3 Kwangdong Botanical Drug Product and Solutions
2.14.4 Kwangdong Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Kwangdong Recent Developments and Future Plans
2.15 GW Pharmaceuticals
2.15.1 GW Pharmaceuticals Details
2.15.2 GW Pharmaceuticals Major Business
2.15.3 GW Pharmaceuticals Botanical Drug Product and Solutions
2.15.4 GW Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 GW Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Botanical Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Botanical Drug by Company Revenue
3.2.2 Top 3 Botanical Drug Players Market Share in 2022
3.2.3 Top 6 Botanical Drug Players Market Share in 2022
3.3 Botanical Drug Market: Overall Company Footprint Analysis
3.3.1 Botanical Drug Market: Region Footprint
3.3.2 Botanical Drug Market: Company Product Type Footprint
3.3.3 Botanical Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Botanical Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global Botanical Drug Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Botanical Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global Botanical Drug Market Forecast by Application (2024-2029)
6 North America
6.1 North America Botanical Drug Consumption Value by Type (2018-2029)
6.2 North America Botanical Drug Consumption Value by Application (2018-2029)
6.3 North America Botanical Drug Market Size by Country
6.3.1 North America Botanical Drug Consumption Value by Country (2018-2029)
6.3.2 United States Botanical Drug Market Size and Forecast (2018-2029)
6.3.3 Canada Botanical Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico Botanical Drug Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Botanical Drug Consumption Value by Type (2018-2029)
7.2 Europe Botanical Drug Consumption Value by Application (2018-2029)
7.3 Europe Botanical Drug Market Size by Country
7.3.1 Europe Botanical Drug Consumption Value by Country (2018-2029)
7.3.2 Germany Botanical Drug Market Size and Forecast (2018-2029)
7.3.3 France Botanical Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Botanical Drug Market Size and Forecast (2018-2029)
7.3.5 Russia Botanical Drug Market Size and Forecast (2018-2029)
7.3.6 Italy Botanical Drug Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Botanical Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Botanical Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Botanical Drug Market Size by Region
8.3.1 Asia-Pacific Botanical Drug Consumption Value by Region (2018-2029)
8.3.2 China Botanical Drug Market Size and Forecast (2018-2029)
8.3.3 Japan Botanical Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea Botanical Drug Market Size and Forecast (2018-2029)
8.3.5 India Botanical Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Botanical Drug Market Size and Forecast (2018-2029)
8.3.7 Australia Botanical Drug Market Size and Forecast (2018-2029)
9 South America
9.1 South America Botanical Drug Consumption Value by Type (2018-2029)
9.2 South America Botanical Drug Consumption Value by Application (2018-2029)
9.3 South America Botanical Drug Market Size by Country
9.3.1 South America Botanical Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil Botanical Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina Botanical Drug Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Botanical Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Botanical Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Botanical Drug Market Size by Country
10.3.1 Middle East & Africa Botanical Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey Botanical Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Botanical Drug Market Size and Forecast (2018-2029)
10.3.4 UAE Botanical Drug Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Botanical Drug Market Drivers
11.2 Botanical Drug Market Restraints
11.3 Botanical Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Botanical Drug Industry Chain
12.2 Botanical Drug Upstream Analysis
12.3 Botanical Drug Midstream Analysis
12.4 Botanical Drug Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Botanical Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Botanical Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Botanical Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Botanical Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Buchang Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 6. Buchang Pharmaceuticals Major Business
Table 7. Buchang Pharmaceuticals Botanical Drug Product and Solutions
Table 8. Buchang Pharmaceuticals Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Buchang Pharmaceuticals Recent Developments and Future Plans
Table 10. China TCM Company Information, Head Office, and Major Competitors
Table 11. China TCM Major Business
Table 12. China TCM Botanical Drug Product and Solutions
Table 13. China TCM Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. China TCM Recent Developments and Future Plans
Table 15. Tsumura Company Information, Head Office, and Major Competitors
Table 16. Tsumura Major Business
Table 17. Tsumura Botanical Drug Product and Solutions
Table 18. Tsumura Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Tsumura Recent Developments and Future Plans
Table 20. Schwabe Company Information, Head Office, and Major Competitors
Table 21. Schwabe Major Business
Table 22. Schwabe Botanical Drug Product and Solutions
Table 23. Schwabe Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Schwabe Recent Developments and Future Plans
Table 25. Tong Ren Tang Company Information, Head Office, and Major Competitors
Table 26. Tong Ren Tang Major Business
Table 27. Tong Ren Tang Botanical Drug Product and Solutions
Table 28. Tong Ren Tang Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Tong Ren Tang Recent Developments and Future Plans
Table 30. Jumpcan Pharmaceutical Company Information, Head Office, and Major Competitors
Table 31. Jumpcan Pharmaceutical Major Business
Table 32. Jumpcan Pharmaceutical Botanical Drug Product and Solutions
Table 33. Jumpcan Pharmaceutical Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Jumpcan Pharmaceutical Recent Developments and Future Plans
Table 35. Guangzhou Baiyunshan Pharmaceutical Company Information, Head Office, and Major Competitors
Table 36. Guangzhou Baiyunshan Pharmaceutical Major Business
Table 37. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product and Solutions
Table 38. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Guangzhou Baiyunshan Pharmaceutical Recent Developments and Future Plans
Table 40. Yunnan Baiyao Company Information, Head Office, and Major Competitors
Table 41. Yunnan Baiyao Major Business
Table 42. Yunnan Baiyao Botanical Drug Product and Solutions
Table 43. Yunnan Baiyao Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Yunnan Baiyao Recent Developments and Future Plans
Table 45. Tasly Holding Group Company Information, Head Office, and Major Competitors
Table 46. Tasly Holding Group Major Business
Table 47. Tasly Holding Group Botanical Drug Product and Solutions
Table 48. Tasly Holding Group Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Tasly Holding Group Recent Developments and Future Plans
Table 50. Bionorica Se Company Information, Head Office, and Major Competitors
Table 51. Bionorica Se Major Business
Table 52. Bionorica Se Botanical Drug Product and Solutions
Table 53. Bionorica Se Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Bionorica Se Recent Developments and Future Plans
Table 55. Huarun 999 Company Information, Head Office, and Major Competitors
Table 56. Huarun 999 Major Business
Table 57. Huarun 999 Botanical Drug Product and Solutions
Table 58. Huarun 999 Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Huarun 999 Recent Developments and Future Plans
Table 60. Taiji Company Information, Head Office, and Major Competitors
Table 61. Taiji Major Business
Table 62. Taiji Botanical Drug Product and Solutions
Table 63. Taiji Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Taiji Recent Developments and Future Plans
Table 65. Weleda Company Information, Head Office, and Major Competitors
Table 66. Weleda Major Business
Table 67. Weleda Botanical Drug Product and Solutions
Table 68. Weleda Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Weleda Recent Developments and Future Plans
Table 70. Kwangdong Company Information, Head Office, and Major Competitors
Table 71. Kwangdong Major Business
Table 72. Kwangdong Botanical Drug Product and Solutions
Table 73. Kwangdong Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Kwangdong Recent Developments and Future Plans
Table 75. GW Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 76. GW Pharmaceuticals Major Business
Table 77. GW Pharmaceuticals Botanical Drug Product and Solutions
Table 78. GW Pharmaceuticals Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. GW Pharmaceuticals Recent Developments and Future Plans
Table 80. Global Botanical Drug Revenue (USD Million) by Players (2018-2023)
Table 81. Global Botanical Drug Revenue Share by Players (2018-2023)
Table 82. Breakdown of Botanical Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Botanical Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Botanical Drug Players
Table 85. Botanical Drug Market: Company Product Type Footprint
Table 86. Botanical Drug Market: Company Product Application Footprint
Table 87. Botanical Drug New Market Entrants and Barriers to Market Entry
Table 88. Botanical Drug Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Botanical Drug Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Botanical Drug Consumption Value Share by Type (2018-2023)
Table 91. Global Botanical Drug Consumption Value Forecast by Type (2024-2029)
Table 92. Global Botanical Drug Consumption Value by Application (2018-2023)
Table 93. Global Botanical Drug Consumption Value Forecast by Application (2024-2029)
Table 94. North America Botanical Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Botanical Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Botanical Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Botanical Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Botanical Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Botanical Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Botanical Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Botanical Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Botanical Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Botanical Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Botanical Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Botanical Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Botanical Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Botanical Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Botanical Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Botanical Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Botanical Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Botanical Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Botanical Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Botanical Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Botanical Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Botanical Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Botanical Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Botanical Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Botanical Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Botanical Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Botanical Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Botanical Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Botanical Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Botanical Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Botanical Drug Raw Material
Table 125. Key Suppliers of Botanical Drug Raw Materials
List of Figures
Figure 1. Botanical Drug Picture
Figure 2. Global Botanical Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Botanical Drug Consumption Value Market Share by Type in 2022
Figure 4. Prescription Drug
Figure 5. OTC
Figure 6. Global Botanical Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Botanical Drug Consumption Value Market Share by Application in 2022
Figure 8. Cardiovascular Picture
Figure 9. Tumor Picture
Figure 10. Respiratory System Picture
Figure 11. Others Picture
Figure 12. Global Botanical Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Botanical Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Botanical Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Botanical Drug Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Botanical Drug Consumption Value Market Share by Region in 2022
Figure 17. North America Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Botanical Drug Revenue Share by Players in 2022
Figure 23. Botanical Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Botanical Drug Market Share in 2022
Figure 25. Global Top 6 Players Botanical Drug Market Share in 2022
Figure 26. Global Botanical Drug Consumption Value Share by Type (2018-2023)
Figure 27. Global Botanical Drug Market Share Forecast by Type (2024-2029)
Figure 28. Global Botanical Drug Consumption Value Share by Application (2018-2023)
Figure 29. Global Botanical Drug Market Share Forecast by Application (2024-2029)
Figure 30. North America Botanical Drug Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Botanical Drug Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Botanical Drug Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Botanical Drug Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Botanical Drug Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Botanical Drug Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 40. France Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Botanical Drug Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Botanical Drug Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Botanical Drug Consumption Value Market Share by Region (2018-2029)
Figure 47. China Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. India Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Botanical Drug Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Botanical Drug Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Botanical Drug Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Botanical Drug Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Botanical Drug Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Botanical Drug Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 64. Botanical Drug Market Drivers
Figure 65. Botanical Drug Market Restraints
Figure 66. Botanical Drug Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Botanical Drug in 2022
Figure 69. Manufacturing Process Analysis of Botanical Drug
Figure 70. Botanical Drug Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
